Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Kimbell Royalty Partners LP Units | KRP | Nov 7, 2024 | 16.83 | +2.75 |
Kimberly-Clark | KMB | Nov 7, 2024 | 132.25 | +0.46 |
Kimco Realty | KIM | Nov 7, 2024 | 24.66 | +1.40 |
Kimco Realty L Pref | KIM-L | Nov 7, 2024 | 23.10 | +0.96 |
Kimco Realty M Pref | KIM-M | Nov 7, 2024 | 23.18 | +0.13 |
Kimco Realty Pref ADR | KIM-N | Nov 7, 2024 | 62.31 | -0.13 |
Kinder Morgan | KMI | Nov 7, 2024 | 26.41 | +0.23 |
Kindercare Learning Companies | KLC | Nov 7, 2024 | 28.40 | 0.00 |
Kindly MD | KDLY | Nov 7, 2024 | 0.85 | -0.04 |
Kineta | KA | Nov 7, 2024 | 0.83 | 0.00 |
Kinetik A | KNTK | Nov 7, 2024 | 56.42 | +7.51 |
Kingsoft Cloud ADR | KC | Nov 7, 2024 | 4.23 | +12.20 |
Kingstone Companies | KINS | Nov 7, 2024 | 11.02 | -2.99 |
Kingsway Financial Services | KFS | Nov 7, 2024 | 9.33 | -2.30 |
Kiniksa Pharmaceuticals | KNSA | Nov 7, 2024 | 23.01 | -0.09 |
Kinross Gold | KGC | Nov 7, 2024 | 10.69 | +8.53 |
Kinsale Capital Group | KNSL | Nov 7, 2024 | 448.26 | -0.74 |
Kiora Pharmaceuticals | KPRX | Nov 7, 2024 | 3.57 | +1.37 |
Kirby | KEX | Nov 7, 2024 | 125.78 | -0.95 |
Kirklands | KIRK | Nov 7, 2024 | 1.74 | +5.45 |
Kite Realty Group Trust | KRG | Nov 7, 2024 | 27.12 | +0.26 |
KKR & Co | KKR | Nov 7, 2024 | 150.71 | -1.02 |
KKR Income Opportunities Fund | KIO | Nov 7, 2024 | 13.79 | +0.77 |
KKR Real Estate Finance Trust | KREF | Nov 7, 2024 | 11.98 | -0.33 |
KKR Real Estate Finance Trust A Pref | KREF-A | Nov 7, 2024 | 21.30 | -0.70 |
KLA | KLAC | Nov 7, 2024 | 686.15 | +2.46 |
Klaviyo | KVYO | Nov 7, 2024 | 33.78 | -16.30 |
KLD 400 Social Index Ishares | DSI | Nov 7, 2024 | 113.75 | +0.99 |
Klotho Neurosciences | KLTO | Nov 7, 2024 | 0.39 | 0.00 |
KLX Energy Services | KLXE | Nov 7, 2024 | 5.67 | +7.18 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.